Regeneron Pharmaceuticals Eulerpool Nieuws

Regeneron Pharmaceuticals Eulerpool News

Regeneron Pharmaceuticals Aandeel Nieuws

Regeneron Pharmaceuticals wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Regeneron Pharmaceuticals nieuwsberichten verzamelen we hier.

• 11 september ·

  Yahoo
  Sanofi, Regeneron's Dupixent Meets Late-Stage Urticaria Study Goals
• 11 september ·

  SeekingAlpha
  Fidelity Select Health Care Portfolio Q2 2024 Review
• 11 september ·

  Yahoo
  EYLEA HD® (aflibercept) Injection 8 mg Data at EURETINA Reinforce Long-term Durability, Sustained Fluid Control and Safety Profile
• 11 september ·

  Yahoo
  Prediction: These 2 Companies Will Split Their Stocks by 2027
• 11 september ·

  Yahoo
  Dupixent succeeds in chronic hives study, giving Sanofi, Regeneron a chance to rebound
• 11 september ·

  GlobeNewswire
  EYLEA HD? (aflibercept) Injection 8 mg Data at EURETINA Reinforce Long-term Durability, Sustained Fluid Control and Safety Profile
• 11 september ·

  Seeking Alpha
  Regeneron, Sanofi report mixed outcomes in late-stage trials for Dupixent
• 11 september ·

  Alliance News
  Sanofi says test of Dupixent shows 50% improvement in skin condition
• 11 september ·

  Yahoo
  Dupixent® (dupilumab) Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria (CSU)
• 11 september ·

  Yahoo
  Dupixent® (dupilumab) Is the First and Only Biologic to Achieve Significant Improvements in Disease Remission and Symptoms in Bullous Pemphigoid (BP) Positive Pivotal Trial